PTC Therapeutics's CEO summarizes a busy year ahead of regulatory decisions and data
- blonca9
- May 14, 2024
- 1 min read
Updated: May 15, 2024
Dr. Matthew Klein provides updates on Translarna, Sepiapterin, Vatiquinone, Utreloxastat, PTC518, and more.

Also look for unique social pages for BiotechTV U.
Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.